We report the case of a 10-year-old child treated for latent tuberculosis infection (LTBI) with pyrazinamide (PZA) and levofloxacin after contact with a smear-positive multidrug-resistant tuberculosis adult. Over the course of the treatment, the patient developed a drug-induced fulminant hepatitis attributed to the combination of PZA and levofloxacin. This case highlights the hepatotoxicity of the association of second-line anti-TB treatment in children.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/INF.0000000000002413 | DOI Listing |
Publication Analysis
Top Keywords
drug-induced fulminant
8
fulminant hepatitis
8
child treated
8
treated latent
8
multidrug-resistant tuberculosis
8
pza levofloxacin
8
hepatitis child
4
latent multidrug-resistant
4
tuberculosis dual
4
dual therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!